Usa US Coronavirus Usa

US FDA authorises Merck's at-home antiviral Covid pill

Reading now: 243
www.rte.ie

The US Food and Drug Administration has authorised Merck & Co's antiviral pill for Covid-19, after giving the go-ahead to a similar treatment from Pfizer Inc yesterday.

Merck's drug, molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce hospitalisations and deaths by around 30% in a clinical trial of high-risk individuals early in the course of the illness.

The agency authorised the oral drug for the treatment of mild-to-moderate Covid-19 in adults who are at risk for severe disease, and for whom alternative Covid-19 treatments are not accessible or clinically appropriate.

The US government has a contract to buy as many as 5 million courses of the drug for $700 per course. The drug is not authorised for use in patients

Read more on rte.ie
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA